Lipella Pharmaceuticals Inc
NASDAQ:LIPO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lipella Pharmaceuticals Inc
NASDAQ:LIPO
|
US |
|
Anritsu Corp
TSE:6754
|
JP |
|
Zamp SA
OTC:ZMMPY
|
BR |
|
Tsukui Staff Corp
TSE:7045
|
JP |
|
U
|
UBS Group AG
SWB:0UB
|
CH |
|
D
|
Daewoo Electronic Components Co Ltd
KRX:009320
|
KR |
|
Broadmedia Corp
TSE:4347
|
JP |
|
V
|
VSTECS Holdings Ltd
HKEX:856
|
HK |
|
A Self-Administered Real Estate Investment Trust Inc
KRX:140910
|
KR |
|
R
|
RWE AG
XBER:RWE
|
DE |
|
Quantum BioPharma Ltd
NASDAQ:QNTM
|
CA |
|
G
|
Garg Furnace Ltd
BSE:530615
|
IN |
|
World Known MFG (Cayman) Ltd
TWSE:4581
|
TW |
|
A
|
Alphabet Inc
BMV:GOOG
|
US |
|
Yutaka Foods Corp
TSE:2806
|
JP |
|
S
|
Sonetel AB (publ)
STO:SONE
|
SE |
|
CCL Products (India) Ltd
BSE:519600
|
IN |
|
G
|
GS P&L Co Ltd
KRX:499790
|
KR |
|
P
|
PVI Holdings
VN:PVI
|
VN |
|
L
|
LGB Forge Ltd
NSE:LGBFORGE
|
IN |
|
KLDiscovery Inc
OTC:KLDI
|
US |
|
G
|
Gaby Inc
CNSX:GABY
|
CA |
|
Buruj Cooperative Insurance Co SJSC
SAU:8270
|
SA |
|
Fortune Information Systems Corp
TWSE:2468
|
TW |
Cash Flow Statement
Cash Flow Statement
Lipella Pharmaceuticals Inc
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(3)
|
(4)
|
(5)
|
(4)
|
(5)
|
(5)
|
(4)
|
(4)
|
(5)
|
(5)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
2
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-59%
|
(4)
-23%
|
(3)
+26%
|
(3)
-19%
|
(3)
-10%
|
(4)
-8%
|
(4)
+1%
|
(4)
-7%
|
(4)
-1%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
5
|
0
|
0
|
0
|
2
|
2
|
2
|
3
|
3
|
6
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
5
0%
|
5
-5%
|
5
N/A
|
1
-73%
|
2
+17%
|
2
+16%
|
3
+45%
|
3
+8%
|
6
+115%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
4
N/A
|
3
-30%
|
2
-35%
|
2
+35%
|
(2)
N/A
|
(2)
-5%
|
(2)
-1%
|
(1)
+45%
|
(1)
-5%
|
2
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-59%
|
(4)
-23%
|
(3)
+25%
|
(3)
-19%
|
(3)
-9%
|
(4)
-8%
|
(4)
+1%
|
(4)
-7%
|
(4)
-1%
|
|